Road map for fibrolamellar carcinoma: progress and goals of a diversified approach

Fibrolamellar carcinoma is a rare liver cancer, which primarily afflicts adolescents and young adults worldwide and is frequently lethal. Given the rarity of this disease, patient recruitment for clinical trials remains a challenge. In November 2017, the Second Fibrolamellar Cancer Foundation Scient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kastenhuber, Edward R, Craig, John, Ramsey, Jon, Sullivan, Kevin M, Sage, Julien, de Oliveira, Sofia, Riehle, Kimberly J, Scott, John D, Gordan, John D, Bardeesy, Nabeel, Abou-Alfa, Ghassan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362920/
https://www.ncbi.nlm.nih.gov/pubmed/30951568
http://dx.doi.org/10.2147/JHC.S194764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362920/
https://www.ncbi.nlm.nih.gov/pubmed/30951568
http://dx.doi.org/10.2147/JHC.S194764

Ejemplares similares